Stem cells given a "return address" cut fractures in women with severe osteoporosis
Stem cells infused into the bloodstream have a bad habit of going everywhere except the bone marrow. A first-in-human trial in Cell fixed that by coating each patient's own mesenchymal stem cells in a special sugar that works as a return address for bone marrow 29.
Ten women over 50 with advanced osteoporosis each got a single infusion. Over the next two years, fractures across the group fell from an average of eight per year to 0.5 per year, a 94 percent sustained decrease 29. Four months in, bone biopsies showed the area occupied by bone tissue was up about 70 percent, and markers of bone formation stayed elevated for half a year 29. Two years out, patients reported 34 percent less bone pain and 30 percent lower disability scores 29.